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In the spring and summer of 1981, an epidemic of a new illness
now referred to as the toxic oil syndrome occurrert in central and
northwestern Spain, resulting in some 20,000 cases, 12,000 hos-
pital admissions and >300 deaths in the 1st year of the epidemic .
The initial onset of illness was usually acute, and patients pre-
sented primarily with a respiratory syndrome involving cough,
fever, dyspnea, hypoxemia, pulmonary infiltrates and pleural
effusions. While approximately 50% of patients recovered from
this acute phase of the illness without apparent sequelae. the
remaining patients developed an intermediate or chronic phase, or
both, of illness involving severe myalgia, eosinophilia, peripheral
nerve damage, sclerodermiform skin lesions, sicca syndrome,
alopecia and joint contractures, among other findings .
The toxic oil syndrome epidemic occurred in Spain in the
spring and summer of 1981 and was one of the largest
epidemics of an intoxication ever recorded, resulting in some
20,000 cases, 12,11011 hospital admissions and >300 deaths
during the 1st 12 months after the epidemic began 11-4).
Information regarding the epidemiology . clinical features
and etiology of the toxic oil syndrome is summarized and
reviewed here, both to provide an overall perspective of
this unusual disease and to provide the background in-
formation necessary for a comprehensive understanding
of the reports that will follow later in this Seminar on
cardiovascular manifestations of the toxic oil syndrome and
related diseases . In addition . information is presented re-
garding the eosinophi :ia-myalgia syndrome- an illness resem-
bling the toxic oil syndrome that occurred in epidemic form
in the United States in 1989 . The implications of this
syndrome for research on the toxic oil syndrome are dis-
cussed.
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f:pidemiologic and analytic chemical studies have dearly
linked the toxic oil syndrome to the ingestion of oil mixtures
containing rapeseed oil drantured with aniline. However, the
precise identity of the etiologic agent within this oil has never been
determined . Aniline itself did not cause the illness, but the causal
agent may he a reaction product of aniline with some nil cnmpn-
nent . Although many aspects of disease activity in the involved
patients have lessened with time, the ultimate consequences of
their disease are not clear and are the subject of ongoing study .
The recently described eosinophilia-myalgia syndrome in the
United States clinically resembles the toxic oil syndrome .
(J Am Coll Cordial 1991 ;18;711-)
Clinical Aspects of the Toxic Oil Syndrome
]lie At tire or Early Phase
The toxic oil syndrome epidemic is often reported to have
started on May 1 . 1981 . the day on which a boy from the
small town of Torrejon de Ardoz, Spain was admitted to a
hospital in Madrid with fulminant respiratory failure that led
rapidly to death (1) . Over the next several weeks . this case
was followed by others in rapidly increasing numbers . So
many acutely ill patients with the toxic oil syndrome pre-
sented for medical attention as to threaten to overwhelm the
capacity for treatment in existing inpatient and outpatient
facilities in affected areas
. During the peak of case occur-
rence in early June. the number of new cases reported each
week approached 2 .000 (1 .4,5) .
Pulmonary involvement. Initially, clinical findings refer-
able to the respiratory system were particularly prominent
.
Typically
. disease manifestations included fever (usually low
grade)- cough, hypoxemia. pulmonary infltrates and pleural
effusions . The pulmonary infiltrates were generally bilateral
and showed an interstitial radiographic pattern
. Neverthe-
less . many severely affected patients had alveolar and inter-
stitiallalveolar infiltrates
(2.3) .
Other acute manifestations . Other disease manifestations
during the acute phase seemed less important than the
dramatic picture of respiratory compromise affecting most
patients who were seen early in the course of their illness
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(within a week or so of onset) . A common accompanying
clinical finding was skin ra
. .h-frequently a maculopapular
erythema
. However, other dermatologic presentations in-
cluded molar erythema or . less frequently, a frank petechial
rash . Some patients had gastrointestinal symptoms . includ-
ing nausea. vomiting or diarrhea . But while such symptoms
were moderately frequent, they were not a particularly
prominent part of the illness . Some patients also had hepa-
tomegaly splenomegaly or lymphadenopathy alone or in
combination
. Serum immunoglobulin E was often elevated .
Biochemical evidence of liver involvement was frequent
.
and mild to moderate elevations of aspsrtate aminotrans-
ferase (AST)
. alaninc aminotransterase (ALT), alkaline
phosphatase and gamma-glutamyl transpeptidase were com .
mon . Increases in serum bilirubin were seen somewhat less
frequently
(1-3,6,7) .
Eosinophilia . One of the most striking findings in all
phases of the toxic oil syndrome was intense peripheral
eosinuphilia. Virtually all patients had absolute eosinophil
counts >500 cells/mm', but counts of >2,0001mm' were
common . Eusinuphilia was so frequent as to he considered a
hallmark of the disease . However, it was occasionally absent
very early in a patient's clinical course, even in the presence
of substantial pulmonary abnormalities (1 .3). Very often the
cosinophilia was accompanied by a more general leukocyto-
sis with a left shift, but the increase in eosinophils was
disproportionate to the increase in absolute numbers of
leukocytes (1,3,5,8) .
The respiratory manifestations of acute toxic oil syn-
drome were generally more intense than those of the eosin-
ophilia-myalgia syndrome (see later) and were frequently
life-threatening . Approximately 1%eof patients with the toxic
oil syndrome died in the acute phase of illness, principally
from respiratory failure (I) .
Intermediate Phase
Many patients with the toxic oil syndrome recovered
from the early phase of illness, apparently without further
clinical sequelae . However, a substantial proportion (per-
haps 50%, the precise percentage varying with the case
series cited) experienced an intermediate and subsequently a
chronic or late phase of illness (3,9) .
Severe myalgia, eosinophitia and thromboembolic cee ;pll-
cations . There is disagreement among investigators regard-
ing both the precise period of illness and the exact clinical
manifestations that should be regarded as constituting the
intermediate phase of the toxic oil syndrome (1 .3)
.
Never-
theless, there is consensus regarding the existence of a more
or less definable period of illness occurring perhaps I to 3
months after the initial onset of symptoms, involving incom-
plete recovery from the acute phase of illness and heralding
the onset of later disease . Extremely severe myalgia (includ-
ing significant muscle tenderness to palpation) and particu-
larly high eosinophil counts (higher even than in the acute
phase) were characteristic of the intermediate phase, and
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many findings of the chronic phase (see later) began to make
their appearance at this point . There was frequently nonpit-
ting edema of the skin of the limbs and other pans of the
body. Although infrequent, there were numerous serious
thromboembolic complications among patients during the
intermediate phase of the syndrome . For example, there
were reports of strokes, mesenteric thromboses and even a
report of hepatic vein thrombosis among patients during this
phase of the illness (2,10)
. In many patients, liver function
tests remained abnormal during the intermediate phase (3 .7) .
Chronic or Late Phase
Neuromuscular complications . The clinical manifesta-
tions of chronic toxic oil syndrome were numerous and
varied . However, neuromuscular complications received
particular attention because of the frequent development of
severe weakness or paralysis . Many patients developed the
findings of mononeuritis multiplex, with patchy sensory loss
and associated muscular weakness. Nerve conduction and
electromyographtc studies typically showed peripheral
nerve axonopathy along with some degree of primary muscle
involvement . The extent of weakness associated with the
neuromuscular lesion differed among patients, but in the
most severe cases there was progression to essentially
complete quadriplegia. In some patients ventilatory function
was compromised and mechanically assisted ventilation was
required . A number of patients eventually died of infectious
complications of long-term mechanically assisted ventilation
(1-3) .
Other manifestations of chronic toxic oil syndrome. These
included severe weight loss, muscle atrophy, chronic myal-
gia, muscle cramps, involuntary movements of the limbs,
scleroderma-like hardening and thickening of the skin, joint
contractures (independent of the limitation in movement
caused by sclerosis of overlying skin), sicca syndrome,
alopecia, pruritus, chronic hepatitis (both hepatic inflamma-
tion and fibrosis) and progressive pulmonary hypertension .
Often, these components of the chronic illness worsened
over a period of months to years (2,3.6,9) . Nevertheless,
recent informal reports of Spanish clinicians (9) suggest that
many aspects of disease activity eventually seemed to lessen
and, finally, to cease.
After the dsemre stops progressing . some degree of
remission of chronic manifestations of the syndrome occurs
.
Peripheral nerve function improves, but often the clinical
gains are modest and come slowly
. Hardened and thickened
skin regains some of its lost elasticity, and other disease
manifestations gradually become less evident .
Pathology
Vascular endothelial swelling and proliferation . The
pathologic lesion common to many tissues in the acute phase
of this multisystemic disorder was swelling of the vascular
endothelium . As the disease progressed through its early .
(ACC Vol . III No . I
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intermediate and chronic phases . intense endothelial prolif-
eration occurred . In many tissues the growth of endothelial
tissue was exuberant, with occlusion or near occlusion of
vessel lumens (11 .12) .
Vasculitis. There were primarily mononuclear inflamma-
tory infiltrates associated with blood vessels . In some tissue
sections only perivascular collections of inflammatory cells
were seen ; in others, there was evidence of a nonnecrotizing
vascutitis (I 1) .
Perineural inflammatory infiltrates and fibrosis . Inflam-
matory infiltrates involved the perineurium of peripheral
nerves . In later stages of the diseases there was perineeral
fibrosis . The muscular lesion involved inflammation primar-
ily of the perimysium and epimysium, with relative sparing
of the endomysium. In the late stages of the toxic oil
syndrome, however, there was endemysial fibrosis . A pecu-
liar finding was inflammation specifically involving muscle
spindles and intramuscular nerves (12) .
Examination of the
bone morrow of patients Irish eosin-
ophilia revealed a marked increase in numbers of eosinophil
precursors .
Epidemiology
There have been three major areas of epidemiologic
research into the toxic oil syndrome : it development of
descriptive data, including information about the demo-
graphics of affected persons, the extent to which different
geographic areas were affected and the occurrence of cases
over time; 2) etiologic epidemiologic studies aimed at iden-
tifying the etiologic agent and its mode of transmission : and
31
studies of the specific clinical findings in affected persons .
their frequency and the extent to which they vary over time .
Descriptive Epidemiology
Although the epidemic has long been said to have begun
on May I . 1981, painstaking and detailed review of comput-
erized patient listings and clinical records has shown that
cases occurred at least as early as April 23 . 1981 linternal
documents . Fondo de Investigation Sanitaria)
. Increasing
numbers of cases occurred throughout May and into early
June 1981 . In mid-June 1981
. the incidence began to de-
crease . This decrease in the epidemic curve coincided ap-
proximately with the public announcement of the association
of the toxic oil syndrome with the consumption of a contam-
inated oil being sold for food use (1 .4) .
Location . The toxic oil syndrome epidemic affected pri-
marily central and northwestern Spain . Over 99% of the
cases officially registered with the Spanish government oc-
curred in the following 14 provinces (listed in rank order
according to the number of cases that occurred there) :
Madrid, Valladolid . Leon . Palencia, Segovia, Avila .
Zamora . Burgos . Guadalajara . Salamanca. Soria, Toledo.
Santander and Orense . Cases were tremendously concen-
trated in Madrid Province, located in central
.Spain, where
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almost 7i' . of the total number occurred
. Flue incidence
rate . however . was not hiehest in Madrid . here- of it,
rclalivdy largo lotal population Other populous cities in
Spain (Barcelona. for example) were essentially unaffected
111 .
Gender distribution, Many more women than men were
affected . At the national level . >60%% of persons with the
toxic oil syndrome were female . Moreover . the disease
seemed it) he more severe for women . There were approx
mately twice as many deaths due to the toxic oil syndrome
among women as among men ( 1) .
Socioeconomic status . The disease had a particularly high
incidence among persons with a low to low-middle socioeco-
nomic status . There was relative sparing of persons with
higher socioeconomic status. but the disease wns also infre-
quent among the very poorest persons in affected areas ( 1) .
Etiolagie Epidrmiologv
Suspect oil, As has frequently been the case in the
solution of complex epidemiologic problems, the astute
Observations of a clinician led to studies that eventually
yielded data firmly implicating the vehicle of the etiologic
agent . Dr . Juan Manuel Tahuenca-Oliver noticed that, al-
though cases fended to cluster in families . children in af-
fected families who were younger than approximately 6
months remained well . Because the nutritional sources of
these infants (generally breast milk) differed substantially
from those of the rest of the family . Tabuenca wondered
whether the vehicle of the toxic oil syndrome agent might be
an ingested item to which most family members (with the
exception of breast-fed babies) were exposed. By question-
ing his patients he found that . essentially without exception .
all of those affected by the syndrome had consumed an
unlabeled food oil, marketed as pure olive oil and sold by
traveling nde,men either door to door or in the weekly open
air markets (rnerradillee)
typical of Spain (5 .13) . Oil fining
this profile in most respects will be referred to as "suspect
oil" in the remainder of this review
.
The oil hypothesis
. A number of studies comparing af-
fected and unaffected persons or families (case-referent
studies) and other epidemiologic work have now established
the validity of the oil hypothesis . The food exposures of 62
children with the toxic oil syndrome were compared with
those of 62 children with other diseases at the Nino Jesus
Hospital in Madrid . All of the children with the syndrome
had consumed suspect oil compared with only 6% of the
children being treated for other problems (13). In the town of
Las Navas del Marques (Avila Province)
. all of 27 case
families had consumed suspect oil compared with only 13
(23ey) of 54 size-matched and 17 (3191 of 54 randomly
chosen control families (4).
In a door to door questionnaire
study conducted in 1981 in the working-class neighborhood
of Orcasur in Madrid
. participants were asked about the
types and sources of oils they consumed . Suspect oil had
been consumed in all five houses surveyed in which cases of
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the toxic oil syndrome had occurred but in only 71 (347,) of
207 unaffected families (14).
The pattern of occurrence of cases of the toxic oil
syndrome among the residents of two convents of the same
order located side by side in the city of Madrid was of
particular interest . The residents of the convents included
nuns, novices and laywomen
. All residents at each convent
ate the same foods . with the exception that nuns and novices
were permitted to use olive oil as a condiment. whereas
laywomen were not. (The "olive oil" used in each convent
at the time of the epidemic was bought from stores and came
in 5-liter plastic contairo-v .) In one convent, 23 (66%) of the
35 nuns and novices but none of 56 laywomen had symptoms
of the toxic oil syndrome. In the other convent, 42 (98%) of
43 nuns became ill while all of approximately 70 laywomen
living there stayed well (15) .
Sources of suspect oil . Work done toward tracing the
sources of suspect oil and chemical analyses of such oils had
shown the oils to be complex mixtures of low quality olive
oil, various seed oils and rapeseed oil . The rapeseed oil
component drew attention because it was not produced in
Spain and could only be imported after being mixed with one
of several denaturants truest commonly aniline) designed to
make it unfit for human consumption . The specific oil vehicle
of the etiologic agent was thus thought to be aniline-
denatured rapeseed oil . but doubts arose regarding this
conclusion when such oils failed to produce illness resem-
bling the toxic oil syndrome in experimental toxicologic
animals (1) . Because the clinical findings of the toxic oil
syndrome are quite distinct from those of aniline toxicity .
the idea arose that perhaps another component of the oil
mixtures carried the etiologic agent . Some even speculated
that some food exposure other than suspect oil was the true
cause of the syndrome .
Aniline-denatured rapeseed oil . A study of oils turned in
to the government by affected and unaffected families and
meeting the general description of suspect oils helped to
resolve these questions . Measurements of specific chemical
analytes in oils turned in by affected families (case oils) were
compared with similar measurements in oils turned in by
unaffected families (control oils) . The results showed a clear
association of illness in a family with the presence of aniline
and fatty acid anilides (reaction products of oil constituents
and the aniline denaturant) in that family's oil . Moreover,
there was a clear-cut dose-response effect : the greater the
extent of contamination, the more likely it was that an oil
had come from an affected family . Consistent with these
findings was the fact that fatty acids and sterols occurring in
particularly high concentrations in rapeseed oil were signif-
icantly higher in case than in control oils . Conversely, the
specific fatty acid and sterol components in which rapeseed
oil is relatively poor were found in reduced concentrations in
case oils
. These findings provided strong evidence to support
the hypothesis that aniline-denatured rapeseed oil land not
some other component of oil mixtures) was the vehicle of the
toxic oil syndrome etiologic agent
(16)
.
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Long-Term Evolution of the Toxic
Oil Syndrome
Mortality
. Data developed to date regarding the long-
term evolution of the toxic oil syndrome are relatively few .
Recent unpublished information (Fondo de Investigacion
Sanitaria) strongly suggests that the current age-adjusted
death rate among affected persons does not differ substan-
tially from that of the Spanish population as a whole .
Although there was a clear-cut and statistically significant
increase in mortality during the Is[ year of the epidemic,
subsequent mortality in a sample of 5% of patients with the
toxic oil syndrome has not differed significantly from that
expected . However, there may have been a tendency for
patients with the syndrome to die at a relatively young age,
and this finding requires further investigation . In general,
these epidemiologic data are consistent with the informal
clinical observation that disease activity diminishes and
disease manifestations tend to regress some months to years
after the onset of illness . Spanish health authorities are
currently implementing further epidemiologic and clinico-
epidemiologic studies that should address more fully the
question of whether excess morbidity or mortality, or both,
is already occurring or may be expected to occur among
persons with the toxic oil syndrome .
Risk of cancer and cardiovascular disease. Patients with
the toxic oil syndrome are particularly concerned about the
possibility that their long-term risk for cancer may have been
increased by their exposure to the toxic ail syndrome agent .
However, given the fact that endothelium and blood vessels
were prime target tissues for the initial insult, the possible
development of cardiovascular disease, cerebrovascular dis-
ease or other vascular diseases is also a concern that should
be addressed in future studies .
Etiology and Pathogenesis
The precise identity of the etiologic agent of the toxic oil
syndrome has yet to be determined . Toxico-epidemiologic
data strongly implicate aniline-denatured rapeseed oil as the
vehicle of the etiologic agent (16)
.
However, the clinical
manifestations of the syndrome are not those of aniline
toxicity . The estimated doses of aniline ingested by patients
were not toxicologically significant and typical manifesta-
tions of aniline poisoning (methemoglobinemia, for example)
were absent (5,13). Thus, unmodified aniline could not have
caused the disease,
Fatty acid anilides. These reaction products, involving an
amide linkage between aniline and fatty acids (the principal
chemical components of edible oils), have been proposed as
the etiologic agents of the syndrome . However, attempts to
reproduce toxic oil syndrome-like biologic phenomena in in
vitro and in vivo systems to which fatty acid anilides have
been added have not, so far, met with unequivocally positive
results (17)
.
Of course, the absence of positive findings in
these experiments is difficult to interpret, because whole .
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implicated oils have failed to produce toxic oil syndrome-like
findings in experimental animals l I I . Thus, the question of
whether the ingestion of fatty acid anilides caused the tonic
oil syndrome remains unanswered .
Chemical contaminants . Other chemical substances de-
rived from the reaction of aniline with other constituents of
rapeseed oil have been proposed as potential etiologic agents
of the toxic oil syndrome 117,18) . However, no convincing
evidence has yet been developed that any particular one of
these compounds was the cause . Thus, all of these hypoth-
eses remain highly speculative .
It is possible that the etiologic agent of the toxic oil
syndrome has nothing to do with aniline . An investigation
sponsored by the Fonda de Investigation Sanitaria (unpub-
lished data) involved a visit to the two French oil companies
from which rapeseed oil implicated in the toxic oil syndrome
epidemic originated. Apparently, rapeseed oil sent to Spain
was taken from undenatured stock !hat was refined and
distributed as edible oil on the domestic French market
without any known adverse health consequences. The com-
panies added aniline to denature their product before send-
ing it to Spain. However . because that denatured product
was theoretically to be employed in industrial processes and
not for use as a food, the usual precautions involved in the
handling and transportation of a food product were not
necessarily taken. The French company exporting the larg-
est quantity of denatured rapeseed oil to Spain hired trucks
that usually carried industrial chemicals . The mixing of
denatured rapeseed oil with some still unknown chemical
contaminant during the process of transport cannot be ruled
out .
Pathogenesis: role of eosinophilia. Data on the pathogen-
esis of the toxic oil syndrome are almost as sketchy as
those on the identity of the etiologic agent . It seems,
however, that cosinophilia may play an important role in the
tissue damage caused by the illness . In many histologic
sections, whole eosinophils are rare among the inflammatory
cells . Nevertheless, eosinophils degranulate in target tissues
and therefore may not appear in histologic sections as intact
cells . In fact, special tests foreosinophil-derived proteins are
positive in tissue sections (12,19) . Thus, tissue damage
caused by eosinophil-derived products may at least partly
explain many of the pathogenetic features of the toxic oil
syndrome .
Treatment
Eariy in the course of the toxic oil syndrome e pidemic . i t
was widely believed that the illness was caused by one of the
microorganisms that commonly produce the syndrome of
atypical pneumonia (4) . Consequently . erythromycin and
tetracycline were widely prescribed . although they had no
apparent effect on the illness 1131 . As the hypothesis of an
infectious cause seemed less tenable, glucocorticoids began
to be employed in therapy . Data regarding their efficacy in
acute toxic oil syndrome are few . but there is a consensus
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that they meliorated pulmonary aspects of the acute phase
of the Illness I2Ill . Cilucoeorticoids caerc vcry effective in
suppressing cosinophilia- but there are no firm data docu-
menting an overall beneficial
effect on the course of inter-
mediate and chronic toxic oil syndrome .
Relation to Other Illness
Appurrrlt Uniqueness of the Taxi('
Oil Strndrotse
Individual clinical findings of the toxic oil syndrome are
seen in other diseases and syndromes . For example, inter-
stitial pulmonary infiltrates can be seen in the hypersensitiv-
ity pncumonitides, a variety of infectious conditions pro-
duced by toxicants that affect the lung (paraquat . for
example) . and many other disease states . The rashes de-
scribed in patients with the toxic oil syndrome are by no
means specific. Eosinophilia is commonly associated with
many parasitic infections, the hypereosinophilic syndrome,
eosinophilic fasciitis . po'yarteritis nodosa and hypersensitiv-
ity reactions to drugs and chemicals, among other condi-
tions . Axonal neurupathy resembling that seen with the toxic
oil syndrome can he produced by conditions that affect the
vascular supply of peripheral nerves, such as diabetes mel-
litus and polyarteritis nodosa
. Some of the skin findings in
chronic toxic oil syndrome resemble those of progressive
systemic sclerosis .
These similarities notwithstanding, the toxic oil syn-
drome was considered a new and distinct clincal entity
because none of the conditions or toxicants just mentimred
produce the sequential evolution of clinical findings seen
among patients with the syndrome: initial respiratory diffi-
culty that resolves over a period of days to weeks only to
lead to severe myalgias. persistent eosinophilia. thromboem-
holic phenomena and late progression to a chronic syndrome
involving neuromuscular compromise, sclerodermiform skin
changes. joint contracmres, chronic hepatopathy and the
other manifestations of chronic toxic oil syndrome
.
The Eo.sittrtphilia-Mvalgia Srwrh-orrte
The uniqueness of the toxic oil syndrome has now been
challenged by the appearance of the cosinophilia-myalgia
syndrome, which occurred in the United States in epidemic
form in 1989 and involved >1 .500 cases 121 .221 . The disease
was apparently caused by contaminated preparations of
t-tryptophan taken as a food supplement (23-25) .
Clinical manifestations of the eosinophilia-myalgia syn-
drome. These are strikingly similar to those of the interme-
diate and chronic stages of the toxic oil syndrome
. Patients
with the eosinophilia-myalgia syndrome typically come to
medical attention because of persistent and severe myalgia,
much like that associated with intermediate and chronic-
and to some extent in acute-toxic oil syndrome .'rhe eosino-
phil count is dramatically increased, usually >2
.000cellsimm' .
There is concomitant leukocytosis, and the bone marrow
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short, Iiypcrplasia ofcosinophil precursors . As in the toxic oil
syndrome
. there are mild to moderate elevations in liver
enzyme levels, and aldolose is frequently increased despite a
normal or minimally elevated creatine kinase level . Muscle
inflammation tends to spare the endomysium and, as in the
toxic oil syndrome, there is selective inflammation of intramus-
culer nerves and muscle spindles (21 .22 .26.27).
Skin lesions and neuropathy . Many patients with the
ensinophilia-myalgia syndrome have skin lesions typical of
cosinophilic fasciitis, and these reports may reflect a lesion
similar to the nonpitting edema described clinically in
patients with the toxic oil syndrome . Sclerodermiform hard-
ening and thickening of the skin occur in the eosinophilia-
myalgia syndrome
. Alopecia. joint contractures and pulmo-
nary hypertension have also been reported . Axonal
neuropathy (mononcuritis multiplex) similar to that seen in
patients wan chronic toxic oil syndrome occurs with the
ensinophilia-myalgia syndrome and is severe among some
patients . with some becoming quadriplegic and ventilator
dependent. As in the toxic oil syndrome, glucocorticoids are
effective in reducing the eosinophil count, but their overall
effect on disease progression, while probably positive, is less
clear-cut (26.27) .
Respiratory syndrome . Many patients with the cosino-
philia-myalgia syndrome have a respiratory syndrome, par-
ticularly early in their illness, typically involving cough and
dyspnca . Interstitial pulmonary infiltrates and pleural effu-
sions have been seen, but less frequently than in acute toxic
oil syndrome . Overall, the respiratory manifestations of the
eosinophilia-myalgia syndrome tend to be either nonexistent
or substantially milder than the typical acute pulmonary
findings of the toxic oil syndrome . This difference in the
degree of respiratory manifestations is perhaps the most
significant factor distinguishing the eosinophilia-myalgia
syndrome from the toxic oil syndrome (22,26.27) .
Implications . Continuing epidemiologic and laboratory
work on the eosinophilia-myalgia syndrome appears likely to
lead soon to the discovery of the specific etiologic agent (28) .
Such a discovery would have substantial implications for
toxic oil syndrome research . Chemical analytic work di-
rected toward examining the possibility that a compound
similar or identical to the eosinophilia-myalgia syndrome
agent existed in case-related toxic oil syndrome oil speci-
mens would become particularly important .
The recent report of a possible animal model of the
eosinophilia-myalgia syndrome is also of interest
(2g) . At-
tempts to develop a similar animal model of the toxic oil
syndrome should continue . Development of a toxic oil
syndrome animal model, if applied in conjunction with
careful chemical work with oils selected by appropriate
epidemiologic techniques, could lead to more precise iden-
tification of the toxic oil syndrome agent even if it hears little
or no chemical similarity to the compound responsible for
the eosinophilia-myalgia syndrome .
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